I’ve been taking a look through the annual report from Wyld, AIM-listed Tern’s second largest investment, for calendar 2021. Needless to say, there was no announcement form Tern over this…..
First thing this morning AIM-listed Trafalgar Property (TRAF) announced a board appointment, and the shares shot out of the traps like rocket on speed, trebling in the first two hours of trading. The excitement was to do with the arrival of Dr Paul Francis Challinor as an executive director. Dr Challinor specialises in indoor hydroponic vertical farming – so the tomatoes-in-test-tubes have returned!
I commented on April 22nd that AIM-listed Pure Gold (PUR), also of the Toronto parish (PGM), in the wake of the admission that without bailout funding it would essentially be toast, that you should take advantage of the market’s stupidity (in marking the shares up to 15.75p) and sell, and that it would be lucky to raise money at more than 10p. And so this morning……
A note out on 26th April 2022 from AIM-listed Origo Partners (OPP)updated its long suffering followers that its shares would be suspended from the month end, as its Nomad, Arden Partners, was being acquired and was giving up on the Nomad business. But since the asset disposal programme was almost finished, the company advised that it was not looking for a replacement. So as of 30 May 2022 Origo’s career of the AIM Casino will be history.
AIM-listed Greek Holiday resort developer Minoan (MIN) released its full-year results to October 2021 last week. It has been a terrible tip as delays and more delays beset a proposed holiday resort at Cavo Sidero in Crete; has there finally been some concrete progress in monetising the asset?
AIM-listed (pro tem) Catenae Innovation (CTEA) updated the market this morning over its suspension from trading due to the non-appearance of its FY account to September 2021. One month down, five to go.
AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) today provided an update in the form of its AGM statement. As ever, it is full of hyperbole but offers few hard numbers. The ShareProphets RNS Translation Service explains all…..
AIM-listed Advanced Oncotherapy (AVO) has updated the market this morning on progress towards its first fully operational LIGHT system. The news is, for a change, good in that there is no further slippage. But will that last?
As we await the latest heavily discounted bucket shop bailout placing – or worse – from AIM-listed UK Oil & Gas (UKOG), we have already had ramptastic 2D seismic processing from its duff Turkish assets and this morning it was announced that CEO Lyin’ Steve Sanderson has been buying shares. Quick, follow the man……..or not!
On 12th April 2022 AIM-listed Advanced Oncotherapy (AVO) announced an equity fundraise of £1.735 million at 25p a pop – a premium to market, but only at par price. We were told that the fundraise has been conducted through a direct subscription with the Company (the "Subscription") for a total of 6,940,000 new ordinary shares. So the money was in the bank, right? Wrong….
